{"nct_id":"NCT02104817","title":"Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2014-10-30","start_date_type":"ACTUAL","primary_completion_date":"2020-05-27","primary_completion_date_type":"ACTUAL","completion_date":"2020-05-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AZN"]}